Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
AKUMS Stock Analysis
Views
Red Flags
Positive
Stock is reasonably valued and PE TTM is at a discount to industry median
Moderate ROE but improving trend
Low Debt to Equity, not much change from last year
Company is net cash
Negative
Analysts have been downgrading forward EPS estimates
Low and declining operating margin
Low revenue growth and lower than median growth of industry
Low dividend yield
Neutral
Company's earnings are of moderate quality
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
AKUMS Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
AKUMS Bulk, Block & Insider Trades
AKUMS Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No dividend events found
No capital change events found
Company Profile
Akums Drugs and Pharmaceuticals Limited is an India-based pharmaceutical contract development and manufacturing company. The Company offers a comprehensive range of pharmaceutical products and services in India and overseas. The Company’s segments include Contract Development and Manufacturing Opera... Read More
Key personnel
Mr. Sumeet Sood
Chief Financial Officer
Mr. Dharamvir Malik
Compliance Officer, Company Secretary
Mr. Sandeep JainD
Managing Director, Executive Director
Mr. Sanjeev JainD
Managing Director, Executive Director
Mr. Sanjay Kumar SinhaD
Whole Time Director, President - Operations
Mr. Sunil Kumar ThakurD
Non-Executive Director
Ms. Matangi GowrishankarD
Independent Director
Mr. Kewal Kundanlal HandaD
Independent Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Akums Drugs & Pharmaceuticals Ltd.?
The current share price of Akums Drugs & Pharmaceuticals Ltd. is ₹ 445.73 as of 09 Jan 2026.
What is the PE ratio of Akums Drugs & Pharmaceuticals Ltd.?
The Price-to-Earnings (PE) ratio of Akums Drugs & Pharmaceuticals Ltd. is 21.39 as of the latest financial data.
What is the ROE and ROCE of Akums Drugs & Pharmaceuticals Ltd.?
Akums Drugs & Pharmaceuticals Ltd. has a Return on Equity (ROE) of 10.66% and a Return on Capital Employed (ROCE) of 8.42% as per the latest financial reports.
What is the market cap of Akums Drugs & Pharmaceuticals Ltd.?
The market capitalization of Akums Drugs & Pharmaceuticals Ltd. stands at ₹ 6,824.22 Cr.
What is the dividend yield of Akums Drugs & Pharmaceuticals Ltd.?
The dividend yield of Akums Drugs & Pharmaceuticals Ltd. is 0.00% based on the current market price.
What is the RSI of Akums Drugs & Pharmaceuticals Ltd.?
The Relative Strength Index (RSI) of Akums Drugs & Pharmaceuticals Ltd. is 53.57.
What is the FII and DII holding in Akums Drugs & Pharmaceuticals Ltd.?
Foreign Institutional Investors (FII) hold 2.27% and Domestic Institutional Investors (DII) hold 7.07% of Akums Drugs & Pharmaceuticals Ltd. shares.
What sector does Akums Drugs & Pharmaceuticals Ltd. belong to?
Akums Drugs & Pharmaceuticals Ltd. operates in the Healthcare sector.
What is the beta of Akums Drugs & Pharmaceuticals Ltd. stock?
The beta of Akums Drugs & Pharmaceuticals Ltd. stock is 1.20, indicating its volatility relative to the broader market.
